ReviewFrontiers in immunology2024

Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the

Xuelian Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.